Results 21 to 30 of about 3,065,508 (250)

Nanofibers as a drug carrier in ophthalmic therapy [PDF]

open access: yesFarmacja Polska, 2021
In ophthalmic therapy, drugs of various structures are used, administered into the conjunctival sac or onto the cornea. Novel concepts of technological development of the form of an ophthalmic drug delivery systems include obtaining a higher ...
Anna Czech   +2 more
doaj   +1 more source

An Integrated Theranostic Nanomaterial for Targeted Photodynamic Therapy of Infectious Endophthalmitis

open access: yesCell Reports Physical Science, 2020
Summary: Infectious endophthalmitis is a growing concern that causes irreversible intraocular tissue and optic nerve damage. Here, we report a theranostic nanoplatform based on UiO-66-NH2 to combine photodynamic therapy (PDT) and lipopolysaccharide (LPS)
Yingying Jin   +9 more
doaj   +1 more source

In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics. [PDF]

open access: yesPharmaceutics, 2020
Mydriasis is required prior to many eye examinations and ophthalmic surgeries. Nowadays, phenylephrine hydrochloride (PHE) and tropicamide (TPC) are extensively used to induce mydriasis.
Destruel PL   +12 more
europepmc   +2 more sources

A Review on Conventional and Novel Topical Ocular Drug Delivery System

open access: yesJournal of Pharmacy, 2021
Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists due to the structural and barrier complexity of the eye.
Mohamad Faeznudin Rozi   +1 more
doaj   +1 more source

Dendrimer and dendrimer gel‐derived drug delivery systems: Breaking bottlenecks of topical administration of glaucoma medications

open access: yesMedComm – Biomaterials and Applications, 2023
Due to high structural flexibility, multidrug carrying capability, and tunable size, dendrimers have been used as suitable carriers for ophthalmic drug delivery. Drug molecules can be either encapsulated or chemically coupled to dendrimers.
Juan Wang   +3 more
doaj   +1 more source

Nanoparticles in ocular applications and their potential toxicity

open access: yesFrontiers in Molecular Biosciences, 2022
Nanotechnology has been developed rapidly in recent decades and widely applied in ocular disease therapy. Nano-drug delivery systems overcome the bottlenecks of current ophthalmic drug delivery and are characterized with strong biocompatibility ...
Cao Yang   +14 more
doaj   +1 more source

Research progress of ophthalmic preparations of immunosuppressants

open access: yesDrug Delivery, 2023
Immune ophthalmopathy is a collection of autoimmune eye diseases. Immunosuppressants are drugs that can inhibit the body’s immune response. Considering drug side effects such as hepatorenal toxicity and the unique structure of the eye, incorporating ...
Ye Liu   +4 more
doaj   +1 more source

Release of functional dexamethasone by intracellular enzymes: A modular peptide-based strategy for ocular drug delivery [PDF]

open access: yes, 2020
Tissue barriers limit drug delivery in the eye. Therefore, retinal diseases are treated with intravitreal injections. Delivery systems with reduced dosing frequency and/or cellular drug delivery properties are needed.
Sadeghi, Amir   +7 more
core   +1 more source

Design of ophthalmic micelles loaded with diclofenac sodium: effect of chitosan and temperature on the block-copolymer micellization behaviour

open access: yes, 2021
Diclofenac sodium 0.1% is a commonly used NSAID with well-documented clinical efficacy in reducing postoperative inflammation; however, its corneal tolerability and ophthalmic tissue bioavailability require further improvement. Advanced micellar delivery
Zoukh, Ikram Mustapha   +13 more
core   +1 more source

Niosomes: A Novel Carrier Drug Delivery System [PDF]

open access: yes, 2021
Niosomes are a novel drug delivery system, in which the medication is encapsulated in a vesicle. The vesicle is composed of a bilayer of non-ionic surfactants.
Shinde, Jitendra V   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy